𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma : A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

✍ Scribed by Antonio Daponte; Paolo A. Ascierto; Adriano Gravina; Maria Teresa Melucci; Giuseppe Palmieri; Pasquale Comella; Riccardo Cellerino; Mario DeLena; Giovanni Marini; Giuseppe Comella

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
90 KB
Volume
89
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-α and chemohormonal therapy f
Interferon-α and chemohormonal therapy for patients with advanced melanoma : Final results of a Phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program
✍ James J. Stark; Robert O. Dillman; Richard Schulof; Michael C. Wiemann; Neil M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Background: The treatment of metastatic melanoma remains unsatisfactory despite encouraging results with biotherapy and combination chemotherapy. combining these two modalities may improve outcomes for such patients. ## Methods: Patients who were eligible for this study had metastatic melanoma

A phase II study of 5-fluorouracil, leuc
A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)
✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext